Treatment Patterns Among Newly Diagnosed Patients with Multiple Sclerosis by Race and Ethnicity
For patients with highly active multiple sclerosis (MS), current treatment guidelines recommend initiation of high-efficacy disease-modifying therapies (DMTs). African American and Hispanic patients are more likely to have highly active disease and experience worse symptom severity and overall disability and may benefit from early use of high-efficacy DMTs; however, little is known about the recent use of specific DMTs after diagnosis and how treatment patterns differ by race and ethnicity. The objective of this study is to describe treatment patterns among newly diagnosed patients with MS by race and ethnicity.
{{assetTitle}}
{{assetDescription}}
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.